Not everyone needs or wants the powerful systemic effects of a GLP-1 agonist
The B-12 is a great energy booster
[6] After parenteral delivery, cyanocobalamin binds transcobalamin II, permitting receptor mediated endocytosis into virtually all nucleated cells
This was confirmed to me by my business partner and genius biochemist Nick Andrews, who had the following to say: Chronic administration has been tested and shown to not generate toxic or negative effects while generating the positive effects observed in adipose tissue as well as muscle tissue. My best guess is that this is supported by what has been seen in animal and cell models thus far: 5-amino-1MQ shows in vivo therapeutic efficacy in murine models of DIO (20 mg/kg/d sc.), muscle injury (5 or 10 mg/kg bid
Given their non-invasive nature and similar clinical performance, these routes may represent suitable alternatives to intramuscular therapy, particularly in settings requiring long-term management
Available from: Pruritus (PDQ)Patient VersionPatient VersionPatient Version- NIH, National Cancer Institute [Internet]